Abstract
The recent development of humanized monoclonal antibody has made antibody therapy, which has many theoretical attractions, an encouraging choice of treatment in hematology/oncology area. This article reviews the basic theory and clinical applications of major antibody therapy, including Herceptin, Rituxan and other antibodies of interest.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
